Diagnosis and Treatment of Prostate Cancer: What Americans Can Learn From International Oncologists

Nicholas James; John Graham; Tobias Maurer; Matthias Eiber; Jürgen E. Gschwend

doi:10.14694/EDBK_175496

Diagnosis and Treatment of Prostate Cancer: What Americans Can Learn From International Oncologists

Nicholas James, John Graham, Tobias Maurer, Matthias Eiber, Jürgen E. Gschwend

University of Birmingham

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

The three main sections in this article illustrate a number of facets of European health care. The first section looks at the influence of NICE on treatment of metastatic castration-resistant prostate cancer. The second section explores the impact of molecular imaging on diagnosis and treatment, in particular the development and clinical implementation of 68Ga PET imaging in prostate cancer. The final section of the session looks at the STAMPEDE trial and how running a trial on this scale has impacted care of prostate cancer in the United Kingdom and also at the uptake of docetaxel chemotherapy in hormone-sensitive advanced disease.

Original language	English
Pages (from-to)	344-357
Number of pages	14
Journal	American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Volume	37
DOIs	https://doi.org/10.14694/EDBK_175496
State	Published - 2017
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.14694/EDBK_175496

Cite this

@article{cac67f968ad64df3aefa320fed00e482,

title = "Diagnosis and Treatment of Prostate Cancer: What Americans Can Learn From International Oncologists",

abstract = "The three main sections in this article illustrate a number of facets of European health care. The first section looks at the influence of NICE on treatment of metastatic castration-resistant prostate cancer. The second section explores the impact of molecular imaging on diagnosis and treatment, in particular the development and clinical implementation of 68Ga PET imaging in prostate cancer. The final section of the session looks at the STAMPEDE trial and how running a trial on this scale has impacted care of prostate cancer in the United Kingdom and also at the uptake of docetaxel chemotherapy in hormone-sensitive advanced disease.",

author = "Nicholas James and John Graham and Tobias Maurer and Matthias Eiber and Gschwend, {J{\"u}rgen E.}",

year = "2017",

doi = "10.14694/EDBK_175496",

language = "English",

volume = "37",

pages = "344--357",

journal = "American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting",

issn = "1548-8756",

publisher = "American Society of Clinical Oncology",

}

TY - JOUR

T1 - Diagnosis and Treatment of Prostate Cancer

T2 - What Americans Can Learn From International Oncologists

AU - James, Nicholas

AU - Graham, John

AU - Maurer, Tobias

AU - Eiber, Matthias

AU - Gschwend, Jürgen E.

PY - 2017

Y1 - 2017

N2 - The three main sections in this article illustrate a number of facets of European health care. The first section looks at the influence of NICE on treatment of metastatic castration-resistant prostate cancer. The second section explores the impact of molecular imaging on diagnosis and treatment, in particular the development and clinical implementation of 68Ga PET imaging in prostate cancer. The final section of the session looks at the STAMPEDE trial and how running a trial on this scale has impacted care of prostate cancer in the United Kingdom and also at the uptake of docetaxel chemotherapy in hormone-sensitive advanced disease.

AB - The three main sections in this article illustrate a number of facets of European health care. The first section looks at the influence of NICE on treatment of metastatic castration-resistant prostate cancer. The second section explores the impact of molecular imaging on diagnosis and treatment, in particular the development and clinical implementation of 68Ga PET imaging in prostate cancer. The final section of the session looks at the STAMPEDE trial and how running a trial on this scale has impacted care of prostate cancer in the United Kingdom and also at the uptake of docetaxel chemotherapy in hormone-sensitive advanced disease.

UR - http://www.scopus.com/inward/record.url?scp=85032810651&partnerID=8YFLogxK

U2 - 10.14694/EDBK_175496

DO - 10.14694/EDBK_175496

M3 - Article

C2 - 28561698

AN - SCOPUS:85032810651

SN - 1548-8756

VL - 37

SP - 344

EP - 357

JO - American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

JF - American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

ER -

Diagnosis and Treatment of Prostate Cancer: What Americans Can Learn From International Oncologists

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this